LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on digital health and AI solutions for Latin America, announced its participation in the Artificial Intelligence & Health Markets 2026 conference, scheduled for August 13-14, 2026, at Universidad Santa Maria in Caracas. The event aims to bring together students, faculty, and professionals from systems engineering and healthcare disciplines to explore practical applications of AI and automation.
The company will be represented by CEO Dr. Kevin Rodan Levy and CFO Carlos Pena, who will discuss the evolving role of AI in healthcare and systems engineering. Their presentation will address how AI-supported tools can assist with medical data evaluation, clinical workflows, and operational decision-making, while emphasizing the importance of maintaining qualified professional oversight to enhance, not replace, human judgment.
This engagement underscores LataMed AI's commitment to fostering education and collaboration in the responsible adoption of digital healthcare infrastructure. By participating in academic forums, the company aims to increase awareness of emerging technologies and gather perspectives from future professionals in healthcare, engineering, and technology fields.
The conference will also cover topics such as integration of AI into existing systems, responsible data use, privacy, security, and operational risk management. LataMed AI plans to highlight its ongoing development of CardioAI, PulmoAI, and NeuroAI platforms, which are designed to assist healthcare professionals in cardiovascular, pulmonary, and neurological health information evaluation.
Dr. Levy stated, "Artificial Intelligence & Health Markets 2026 provides an important opportunity to engage directly with students, educators, and future professionals who will help shape the responsible use of AI in healthcare and systems engineering. Our objective is to share practical perspectives on how intelligent technologies can support professional decision-making, improve digital workflows, and contribute to the continued development of healthcare infrastructure in Latin America."
The company's participation aligns with its broader strategy of supporting education and professional collaboration. However, it does not guarantee future research collaborations or commercial relationships. For more information, visit https://latamed.ai or review filings with the SEC at www.sec.gov.
